Skip to main content
OpenTrials
Completed

NCT Number: NCT00509886

Non-prescription Versus Prescription Topical Treatments Versus no Treatment in the Control of Sweating

The purpose of this study is to assess the effectiveness of the prescription treatment compared to the non-prescription treatment. It is hypothesized that the prescription treatment will have a significantly greater effect than the non-prescription treatment on decreasing excess sweating.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hyperhidrosis Excess Sweating Skin Diseases Skin and Connective Tissue Diseases Sweat Gland Diseases

Age range

21 year–30 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Northwestern University Dermatology

Chicago, Illinois, 60611, United States

About this study

The objective of this study is to assess the effectiveness of the prescription treatment compared to the non-prescription treatment. It is hypothesized that the prescription treatment will have a significantly greater effect than the non-prescription treatment on decreasing excess sweating.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age 21-30 years
  • males and females
  • The subjects are in good health.
  • The subjects have willingness and the ability to understand and provide informed consent for participation in the study.

Exclusion criteria

  • Subjects with primary hyperhidrosis
  • Subjects who are unable to withstand prolonged heat exposure or who have self-reported history of cardiovascular or respiratory disorders.
  • Subjects who are unable to give informed consent.
  • Subjects with mental illness.
  • Subjects who are pregnant or nursing.
  • Subjects with systemic or local skin disease and/or infection that may interfere with the conduct of the study.

Treatment and study plan

Drysol

Drug

20% aluminum chloride hexahydrate

Drioff

Drug

1% aluminum acetate

Primary outcomes

  1. Gravimetric analysis

    Time frame: 3 hours

Secondary outcomes

  1. Subject sweat assessment

    Time frame: 3 hours

  2. HDSS

    Time frame: 3 hours

Sponsors and collaborators

Lead sponsor

Northwestern University

Other

Registry information

Important dates

Study start
2007
Primary completion
2007
Study completion
2007
First posted
Aug 1, 2007
Registry last updated
Nov 10, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.